Health Ministry Price Controller Vadim Ferman announced the maximum prices of prescription drugs with controlled patents under the Control of Commodities and Services Law will fall by an average of 6.9% on January 1, 2019, relative to the current price.
This change was mainly caused by a change in the price control model for prescription drugs led by Deputy Health Minister MK Yaakov Litzman and Finance Minister MK Moshe Kahlon.
The goal of the model was to allow Israeli citizens access to expensive drugs that are not competitive and therefore sold at a high price.
Read more at Arutz Sheva.
{Matzav.com}
